1/35
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
What does Peto’s Paradox explain
Why don’t whales get cancer - increased ratio of tumour suppressor genes to oncogenes
What’s p53
Guardian of the genome - tumour suppressor gene (TSG) - halt cell growth
Chemotherapy vs Refined chemotherapy vs Targeted MAB therapy
Chemotherapy kill every cell that divides
Refined chemo kills most rapidly dividing cells
Targeted MAB kill only cancer cells that have this target
Match the molecular target to each cancer: GI/Colorectal, Lung, Breast, Melanoma
ROS1, KRAS, EGFR, NRAS, BRAF, MSI/MMR, Oncotype, Her2, ER, PR, Kit, PDGFR, PIK3Ca, PDL1, NTRK, Alk, CKIT, BRCA, Ki67
GI/Colorectal: KRAS, NRAS, BRAF, MSI/MMR, Her2, Kit, PDGFR, PDL1, NTRK
Lung: EGFR, KRAS, NRAS, BRAF, MSI/MMR, Her2, kit, PDGFR,PDL1, Alk, ROS1, NTRK
Breast: ER, PR, Her2, PIK3Ca, PDL1, Oncotype, BRCA, Ki67, NTRK
Melanoma: BRAF, PDL1, NTRK, CKIT(mucosal melanoma)
In which molecular targets is the gene altered (e.g. insertion / deletion)
KRAS, NRAS, BRAF, EGFR, PDGFRa, CKIT, PIK3CA
In which molecular targets is the chromosome altered (e.g. oncogene is paired with another driver gene)
ALK, ROS1, NTRK
In which molecular targets is the gene important in protecting against cancer (e.g. oncogene is paired with another driver gene)
MSI/MMR
In which molecular targets does the gene hide the cancer from the immune system
PDL1
In which molecular targets does the gene have increased expression
HER2, ER, PR


What does PCR/Sequencing allow use to know
Looks at the genetic code in sequence
How does PCR work
• Amplify the target DNA with PCR
• For single gene tests can just use PCR product expansion to detect gene variants
• Or for multiple genes can do massive parallel sequencing AKA Next Generation Sequencing (NGS)
Explain the process of Next Generation Sequencing
• Tumour tissue sample
• Extract DNA
• Create a DNA (RNA sometimes) library
• Amplify the library on beads
• Sequence from the beads

2 options for sequencing methods
Ion detection(Ion torrent)
Colorimetric (Illumina)
EGFR sensitising mutation in lung cancer means it will respond to what treatment
Tyrosine kinase inhibitors (TKIs)
EGFR sensitising mutation in lung cancer means it will respond to Tyrosine kinase inhibitors (TKIs), except if they have what mutation
Unless there is a resistance mutation e.g T790M
What does ISH/Sequencing allow use to know
Looks at the structure of the chromosome - Detection of fusion oncoproteins which are constitutively activated by a translocation
Explain the process of FISH
• Fusion probe or break apart probe to detect these
• Two probes around the ALK gene
• Both fluoresce different colours
• When a fusion occurs they “break apart” and are separated
• If normal then they are overlapping
• Doesn’t tell you the partner gene but tells you there is a translocation present

If there is an ALK or ROS translocation in non-small cell lung cancer then the patient may respond to what treatment
Crizotinib
Neurotrophic tyrosine kinase receptor (NTKR) family is seen in lots of cancers. Where is it found & what does it do
Membrane bound receptor involved in cell differentiation
Cancers with the NTRK biomarker generally repsond well to what treatment
entrectinib
What does Immunohistochemistry allow use to know
Looks at the protein expression
How does IHC work
Use monoclonal antibodies to detect the proteins (antigens) expressed on tumour tissue on a glass slide
If a breast cancer expresses hormone receptors, (O)Estrogen or Progesterone, ER or PR then the patient will respond to what treatment
Anti-hormone therapy - tamoxifen
If a breast cancer overexpresses Her2 then the patient may receive what therapy
Herecptin - a monoclonal antibody therapy against the Her2 protein
Her2 is found where & does what
Surface receptor
Responsible for growth
Her2 is aka (2)
Her/neu, ERBB2
Her2 overexpression is seen in what 3 cancers mainly
breast cancer
gastric cancer
colorectal cancer
Her2 protein overexpressed on the tumour surface will score positive on IHC. But how can we test for it when it isn’t very strong?
In situ hybridisation (DDISH/FISH)
Most important 4 Mismatch repair proteins
• MLH1
• PMS2
• MSH2
• MSH6
(When working the four combine to repair mismatches in the DNA)
What would infer that the problem with the cancer is an issue with he MMR proteins
If errors are detected in microsatellite region then this infers problems with the protein expression
MMRs would usually fix these
How do we detect a lack of a functional MMR gene
By negative IHC
(as in if there’s no expression that’s considered the problem - different to a + IHC)
Can also be tested by DNA analysis of the microsatellite regions
2 possible causes of MMR deficiency
Lynch Syndrome
Muir Torre Syndrome
What does PDL1 stand for
Programmed death-ligand 1 (PD-L1)
Role of PD-L1
Aliases CD274 and B7-H1 → dampens down the immune response through decreased T cell proliferation
What can we find out from a liquid biopsy
